21 results
6-K
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:05am
been named as a defendant in lawsuits in U.S. federal and state courts in which plaintiffs allege to have developed bladder cancer or other injuries … claiming similar injuries.
In April 2015, Takeda reached an agreement with the lead plaintiffs’ lawyers that resolved the vast majority of ACTOS
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:03am
in which plaintiffs allege to have developed bladder cancer or other injuries as a result of taking products containing type 2 diabetes treatment … . Outside the U.S., lawsuits and claims have also been brought by persons claiming similar injuries. In April 2015, Takeda entered into a settlement
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
and safety we will continue to explore new ways to measure, Occupational injuries of our employees and the understand, and communicate the full picture … LOST WORKDAYS. us to understand the root cause of incidents and 2 NUMBER OF WORKERS’ INJURIES WITH DAY(S) OFF PER 1 MILLION quickly take steps
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:14am
. ACTOS Economic Loss Cases Takeda has been named in an ACTOS-related lawsuit brought by plaintiffs who do not assert any claims for personal injuries … proceedings in a multi-district litigation in federal court in New Jersey. The plaintiffs in these cases allege they developed kidney injuries or, in some cases
20FR12B/A
EX-10.13
TAK
Takeda Pharmaceutical Co
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
Purchasers or the Holders for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely
20FR12B
EX-10.13
dmu 6a75w8
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
6-K
EX-99.1
4q890
31 May 22
Current report (foreign)
12:00am
20FR12B/A
l13k l7p02966vrt
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
xm17ke3ll6wg7v7
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
s1aj7ktaavjtzft np
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
6-K
EX-99.1
syeg3bq
6 Jul 23
Current report (foreign)
6:18am
F-4/A
66e2oekatdx7z
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
5eeu2
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
vp7uoirdu eedh
27 Jun 19
Annual report (foreign)
6:41am
424B3
3n2t xoaav9di
14 Nov 19
Prospectus supplement
6:10am
6-K
EX-99.1
xsc9fvhnn7qhcxiqe
17 Dec 20
Current report (foreign)
6:01am